prof. MUDr. Jindřich Špinar, CSc.
Professor, First Department of Internal Medicine - Cardioangiology
Correspondence Address:
Pekařská 664/53, 602 00 Brno
Phone: | +420 532 23 2601 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 1172
2022
-
Comparison of Patients with Reduced and Mildly Reduced Left Ventricular Ejection Fraction: Intermediate Data from the FAR NHL Registry
Applied Sciences, year: 2022, volume: 12, edition: 21, DOI
-
Empagliflozin benefits in patients with heart failure and preserved ejection fraction
NATURE MEDICINE, year: 2022, volume: 28, edition: 12, DOI
-
Multicentrická, observační, prospektivní studie zaměřená na úroveň diagnostiky a léčby chronického srdečního selhání v České republice – MOST HF. Zdůvodnění a uspořádání studie
cor et Vasa, year: 2022, volume: 64, edition: 6, DOI
-
Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE–TIMI 58 trial
European Heart Journal, year: 2022, volume: 43, edition: 31, DOI
-
Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B
Circulation, year: 2022, volume: 146, edition: 12, DOI
-
Relation between Mid-Regional Pro-Adrenomedullin in Patients with Chronic Heart Failure and the Dose of Diuretics in 2-Year Follow-Up-Data from FAR NHL Registry
Medicina-Lithuania, year: 2022, volume: 58, edition: 10, DOI
-
Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shock
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, year: 2022, volume: 11, edition: 10, DOI
-
Souhrn Doporučených postupů Evropské kardiologické společnosti pro diagnostiku a léčbu srdečního selhání z roku 2021
cor et Vasa, year: 2022, volume: 64, edition: 2, DOI
2021
-
Blokátory AT1 receptoru pro angiotenzin II (sartany) v léčbě kardiovaskulárních onemocnění
Arteriální hypertenze - Současné klinické trendy XIX, year: 2021
-
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
New England Journal of Medicine, year: 2021, volume: 384, edition: 2, DOI